CFO departure
Petros Pharmaceuticals, Inc. discloses CFO departure: Robert Weinstein
Petros Pharmaceuticals, Inc. reported in a Form 8-K filed September 30, 2026 a change involving its Chief Financial Officer, Robert Weinstein, effective September 30, 2026. The filing's own words are quoted below.
In the filing's words
effective as of September 30, 2026 at 5:30 p.m. Eastern time, Robert Weinstein resigned as Chief Accounting Officer, Principal Financial Officer, and Principal Accounting Officer of the Company.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Petros Pharmaceuticals, Inc. (PTPI) |
|---|---|
| Event | Departure |
| Outgoing | Robert Weinstein |
| Effective | September 30, 2026 |
| 8-K filed | September 30, 2026 |
| SEC CIK | 0001815903 |
Petros Pharmaceuticals, Inc. reported this change in a Form 8-K, Item 5.02, filed September 30, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-10-01
Something wrong about Robert Weinstein? Send a correction with the primary source.